Dimensional Fund Advisors
GNMK

Dimensional Fund Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Dimensional Fund Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-21,960
Closed -$119K – 3391
2018
Q1 		$119K Hold
21,960
– – ﹤0.01% 3272
2017
Q4 		$92K Buy
+21,960
New +$132K ﹤0.01% 3279
2013
Q3 		– Sell
-477
Closed -$5K – 3584
2013
Q2 		$5K Buy
+477
New +$6.58K ﹤0.01% 3548

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Dimensional Fund Advisors's GNMK Position: Q2 2018 in Review

Dimensional Fund Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2018, closing a stake of 21,960 shares — an estimated $119K sold.

Dimensional Fund Advisors first reported a position in GNMK in Q2 2013 and held it in 3 quarters. The position peaked at $119K in Q1 2018. 105 funds tracked by Wall St. Rank hold GNMK as of Q2 2018.

  • Dimensional Fund Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 21,960 GenMark Diagnostics, Inc shares in Q2 2018, an estimated $119K.
  • Dimensional Fund Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 3 quarters.
  • Dimensional Fund Advisors's GenMark Diagnostics, Inc position peaked at $119K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2018.

Based on Dimensional Fund Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.